Opportunities to join

Vækstfonden’s portfolio companies
Hoba Therapeutics
Hoba Therapeutics
healthcare & life science

Hoba Therapeutics was established November 2016 and funded by Novo Seeds and Borean Innovation. The company is developing biopharmaceuticals for the treatment of pain and CNS disorders. Our pipeline includes two patented endogenous neurotrophic factors with shared properties. The lead compound is HB-086 (human recombinant Meteorin) and preclinical studies support therapeutic use in neuropathy and associated neuropathic pain. HB-097 (human recombinant Cometin) is in early preclinical development for hearing disorders. Our mission is to provide innovative effective, safe and disease modifying treatments to patients living with neuropathic pain.
Copenhagen, Denmark
Inaccurate data? Flag it here.
Open jobs at Hoba Therapeutics
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.
We only use strictly necessary, first-party cookies on this job board. These are cookies that are necessary to deliver this service to you, or are necessary for Vækstfonden to understand how it is being used. Read our Cookie Policy.